“Selectively applied, the declassification process can become political and sleazy,” according to an editorial in the Buffalo News. See “Cheney misuses expanded powers,” February 18.
The spectrum of opinion and analysis on the Vice President’s declassification authority was surveyed in “Cheney’s Secret Powers” by Dan Froomkin, White House Briefing, February 17.
“Another House Republican committee chairman has joined criticism of the Congressional Research Service for its legal analysis of the administration’s program of counterterrorist electronic surveillance.” See “Lawmaker hits wiretap memo” by Shaun Waterman, UPI/Washington Times, February 20.
Improving public awareness of FDA Advisory Committees would improve public trust and deter misinformation related to the approval of medical products.
FAS has been a leading voice for action on this topic, and has developed a compendium of 150+ heat-related federal policy recommendations.
Proposed bills advance research ecosystems, economic development, and education access and move now to the U.S. House of Representatives for a vote
The absence of consistent voting privileges for patient representatives on Advisory Committees hinders representatives from providing an voice on behalf of the community they represent.